New stroke treatment proves effective, both medically and financially

January 4, 2017 by David Orenstein  , Brown University
In this illustration a clot in the brain deprives the grayed out area of blood supply. A new treatment appears cost-effective in treating the clots. National Institute of Neurological Disorders and Stroke. Credit: Brown University

As soon as possible after a stroke, a critical step is to eliminate the clot that caused it. While the current standard of care is to use "clot busting" tissue-type plasminogen activator drugs, recent studies have shown greater medical efficacy in combining the drugs with a "stent retriever" that mechanically opens the artery for a device to grab it and pull it out—a surgical procedure called "thrombectomy."

The question remained, however, of whether the added procedure was cost-effective. A new study co-authored by Theresa Shireman, professor of health services, policy and practice at the Brown University School of Public Health, found that it is. After higher initial costs, Shireman explains in the interview below, better outcomes for patients make -related care less costly in the long run.

Shireman was lead author of the study published in the journal Stroke.

To compare the cost-effectiveness of one treatment vs. another, what did you measure?

In general, new technologies or treatments in health care cost more than the existing standard of care. In cost-effectiveness analysis, the purpose is to judge the relative increase in costs against the presumably improved benefit or effect. There are occasions, however, where a new treatment provides greater benefit or effect at a lower cost. That is the case with the technology we analyzed.

How much more cost effective was treatment with the mechanical thrombectomy plus the drug than treatment with the drug alone?

In the case of the technology we assessed, it made the initial hospitalization for more expensive (the cost of actually doing the procedure) but patients improved so much in their stroke recovery that long-term costs were lower. In other words, patients' recovery with respect to physical function was so much better with stent retriever thrombectomy that they were less likely to need nursing home rehabilitation and longer . This saved money so that within 22 months, the higher procedure costs had been covered.

Does cost-effectiveness (rather than care effectiveness) matter to patients and their families or only to insurers and providers?

Cost-effectiveness should matter to all of us, as it is one approach to finding the most efficient health care interventions—those that generate the greatest benefit at the lowest cost. If we regularly find the most efficient interventions, we all will pay less for and have the best outcomes. In the case of stent retriever thrombectomy, it is easy to see the patient and family benefits, as they have better functional recovery post-stroke and are less likely to need nursing home care. That's a double-win for them and for payers and providers. In many cases, however, cost-effectiveness analyses may not generate such clear results, and not all analyses adhere to consensus guidelines.

How might these findings affect stroke treatment in the future?

For patients who suffer an ischemic stroke and are located close enough to a stroke center or hospital with the appropriately trained interventionist, access to stent retriever thrombectomy should be able to dramatically reduce the burden of stroke.

What was your role in the study?

The project was designed by Dr. David Cohen and his team at the Saint Luke's Mid-America Heart Institute in Kansas City, Missouri. I served as the lead investigator, shepherding the project through its various phases, reviewing intermediate steps, presenting the findings at an international conference and preparing the final manuscript.

Explore further: Some stroke treatments proven to reduce health care costs

More information: Theresa I. Shireman et al. Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke, Stroke (2016). DOI: 10.1161/STROKEAHA.116.014735

Related Stories

Some stroke treatments proven to reduce health care costs

July 27, 2015
Use of mechanical thrombectomy on qualifying stroke patients could result in major savings to the healthcare economy in the United Kingdom (U.K.) and other western countries with a similar healthcare structure, according ...

New study 'game-changer' for stroke treatment worldwide

February 11, 2015
A landmark study published in the New England Journal of Medicine today heralds a new era in stroke treatment across the globe.

New neuroendovascular technique shows promise in stroke patients with large-vessel clots

June 29, 2016
In an article published online April 16, 2016 by the Journal of Neurointerventional Surgery, investigators at the Medical University of South Carolina (MUSC) report promising 90-day outcomes for stroke patients with large-vessel ...

Clot removal may save money and limit disability

February 17, 2016
Adding mechanical clot removal to clot-busting drugs could lower stroke survivors medical bills, decrease government healthcare as well as non-healthcare related costs, and increase the likelihood of the patient returning ...

New devices causing 'paradigm shift' in stroke care

June 24, 2016
New devices called stent retrievers, which effectively reverse strokes, have revolutionized the treatment of certain stroke patients, according to an article in the journal Expert Review of Neurotherapeutics.

Workforce processes prior to mechanical thrombectomy vary widely, new study finds

July 26, 2016
Mechanical thrombectomy, a leading type of neurointerventional stroke treatment where a device can remove a blood clot in minutes, is essential for people experiencing a stroke, who stand to lose 2 million neurons every minute ...

Recommended for you

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

Place of residence linked to heart failure risk

January 9, 2018
Location. Location. Location.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.